Integrated Safety Summary of Phase II and III Studies Comparing Oral Nemonoxacin and Levofloxacin in Community-Acquired Pneumonia
ConclusionNemonoxacin was well tolerated and no clinically significant safety concerns were identified, suggesting that it possesses a desirable safety and tolerability profile similar to that of levofloxacin, and may be a suitable alternative to fluoroquinolones for treating patients with CAP.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Allergy & Immunology | Electrocardiogram | Gastroenterology | Hematology | Levaquin | Microbiology | Pneumonia | Study | Superbugs